Validea Kenneth Fisher Strategy Daily Upgrade Report

Validea's Price/Sales Investor model, based on Kenneth Fisher's strategy emphasizing low price/sales ratios, long-term profit growth, strong free cash flow, and consistent profit margins, recently upgraded two stocks. Amarin Corp (AMRN) saw its rating increase from 40% to 60%, though it remains below the 'some interest' threshold and exhibits several fundamental weaknesses according to the model's criteria. Conversely, Ebara Corp (EBCOY) received a significant upgrade from 68% to 90%, indicating 'strong interest' from the strategy due to its alignment with most key fundamental metrics.

Analysis

Validea's quantitative model, based on Kenneth Fisher's strategy, has issued divergent signals on two equities. Ebara Corp (EBCOY) received a significant rating increase from 68% to 90%, moving it into the model's 'strong interest' category. This upgrade is fundamentally driven, as the mid-cap Japanese industrial firm passed key criteria for long-term EPS growth, free cash per share, and three-year average net profit margin, alongside favorable debt and valuation ratios. The company's diversified operations across energy, infrastructure, and electronics provide a broad base for this positive assessment. In contrast, Amarin Corporation (AMRN), a small-cap pharmaceutical company, saw its rating rise from 40% to 60%, a level that remains below the model's 80% 'some interest' threshold. While AMRN passed initial tests on its price-to-sales and debt-to-equity ratios, it failed on critical fundamental metrics, including long-term EPS growth, free cash flow generation, and average net profit margins, reflecting underlying weakness despite the improved score.

Key Decisions for Investors

• Investors aligned with value and growth principles should consider Ebara Corp (EBCOY) for further due diligence, as its 90% score indicates strong alignment with a model rewarding fundamental strength in cash flow, profit growth, and margins.
• Caution is advised regarding Amarin (AMRN); the upgrade to 60% appears driven by valuation metrics while masking significant fundamental failures in profitability and cash generation highlighted by the same model.
• The contrasting signals emphasize the need to analyze the components of a quantitative score, as EBCOY's rating is supported by broad fundamental health while AMRN's rating reflects a more tenuous, valuation-based improvement.